// App-Quantinova.ai

1924 : The impact of treatment of chronic hepatitis B (CHB) on patient‐reported outcomes (PROs)

Researchers

Presenter

  • Zobair M. Younossi

Principal Investigators

  • Maria Stepanova

  • Harry L. Janssen

  • Kosh Agarwal

  • Mindie H. Nguyen

  • Edward J. Gane

  • Naoky C. Tsai

  • Issah Younossi

  • Sharon Hunt

Medical Centers

  • Center for Liver Disease, Department of Medicine, Inova Fairfax Hospital, Falls church, Virginia, United States

  • Center for Outcomes Research in Liver Disease, Washington DC, VA

  • Gastroenterology & Hepatology University Health Network, Toronto General Hospital, Toronto, ON, Canada

  • King's College Hospital, Institute of Liver Studies, London, United Kingdom

  • Stanford Univ, Palo Alto, CA

  • New Zealand Liver Transplant Unit, Auckland City Hospital, Auckland, New Zealand

  • Liver Center Univ Hawaii SOEST, Honolulu, HI

Locations

  • United States

  • Canada

  • United Kingdom

  • New Zealand

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Chronic Liver Disease

  • Hepatitis B

Biomarkers

  • N/A

Drug/Treatment

  • Tenofovir disoproxil fumarate

  • Vesatolimod

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved